Establishing the model of kappaB-decoy inhibiting the activity of NF-kappaB in PC12 cells.
- Author:
Dong-mei WANG
1
;
De-zheng GONG
;
Sheng-ming YIN
;
De-qin YU
;
Hong XU
;
Jing XU
;
Jie ZHAO
;
Yi-ping SUN
Author Information
- Publication Type:Journal Article
- MeSH: Animals; Cells, Cultured; Lipopolysaccharides; pharmacology; NF-kappa B; antagonists & inhibitors; metabolism; Oligodeoxyribonucleotides; pharmacology; PC12 Cells; Rats
- From: Chinese Journal of Applied Physiology 2010;26(2):195-198
- CountryChina
- Language:Chinese
-
Abstract:
OBJECTIVEObserving the time course and establishing the model of kappaB-decoy oligodeoxynucleotides (rcB-decoy) inhibiting the activity of NF-kappaB in the PC12 cells.
METHODSPC12 cells cultivating in the 6 wells plate were divided into 3 groups, experimental group: adding kappaB-decoy complex (6 microg DNA/well), the control group: adding scrambled-decoy complex, the normal group: adding lipid-Lipofectamine 2000, transfer and cultivate 48 h, then lipopolysaccharide (LPS, 200 ng/ml) was added in the cells for 0.5-4 h. The immunocytochemistry and Western blot were used to measure the expression or the activity of NF-kappaB in PC12 cells.
RESULTSIn PC12 cells, compared with normal group, the expression of NF-kappaB enhanced obviously with the time of the stimulation of LPS in scrambled-decoy treated control group (P < 0.01), in 2-4 h the level reached the peak; the expression of NF-kappaB showed the stable level with the time of the stimulation of LPS in kappaB-decoy treated experimental group, compared with the control group, the expression levels were obviously lower than the respective time point of control groups (P < 0.01).
CONCLUSIONkappaB-decoy could reduce the expression of NF-kappaB in the normal PC12 cells and inhibit the activity of NF-cB in the pathologic PC12 cells.